Latest News about NVAX
Recent news which mentions NVAX
From Motley Fool
Should You Buy Johnson & Johnson For Its COVID Vaccine?
January 18, 2021
From Motley Fool
Here Are the Most Compelling Buys of the COVID Vaccine Stocks
January 17, 2021
From Motley Fool
This Is the Best News Yet for Moderna's COVID Vaccine
January 17, 2021
From Motley Fool
From Motley Fool
Why I'm Not Buying Vaxart Stock
January 16, 2021
From Motley Fool
3 Fantastic Coronavirus Vaccine Stocks to Buy Right Now
January 16, 2021
From Motley Fool
Novavax Hires Regulatory Expert As Coronavirus Vaccine Inches Closer To Emergency Use Filing
January 15, 2021
From Benzinga
Is Novavax's Growth Story Over?
January 15, 2021
From Motley Fool
Better Buy: Novavax vs. Moderna
January 15, 2021
From Motley Fool
2 COVID Vaccine Stocks That Could Trounce Pfizer and Moderna in 2021
January 14, 2021
From Motley Fool
My Best Coronavirus Stock for 2021
January 13, 2021
From Motley Fool
From MarketWatch
Here Are the Next COVID Vaccines About to Cross the Finish Line
January 12, 2021
From Motley Fool
2 Investing Mistakes to Avoid Like the Plague in 2021
January 12, 2021
From Motley Fool
My Best Coronavirus Vaccine Stock for 2021
January 10, 2021
From Motley Fool
3 Top Biotech Picks for 2021
January 10, 2021
From Motley Fool
Novavax Strikes Another Coronavirus Vaccine Supply Deal: Where Does The Company's Program Stand?
January 08, 2021
Tickers
NVAX
From Benzinga
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
January 08, 2021
From Benzinga
From Motley Fool
Moderna Has Big Plans For 2021
January 07, 2021
From Benzinga
Where to Invest $100,000 Right Now
January 07, 2021
From Motley Fool
2 Under-the-Radar COVID Vaccine Stocks to Buy for 2021
January 07, 2021
From Motley Fool
The 10 Best-Performing Stocks of 2020
January 07, 2021
From Motley Fool
Forget Bitcoin: This Stock Is a Better Buy
January 07, 2021
From Motley Fool
3 Things to Expect from Novavax in 2021
January 06, 2021
From Motley Fool
2021 Could Be Novavax's Year
January 06, 2021
From Benzinga
Virus Plays in Focus as 2021 Gets in Gear (NASDAQ: NVAX) (OTC US: HALB) (NASDAQ: MRNA)
January 06, 2021
From OTC
3 Big Potential Catalysts for Moderna in 2021
January 06, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.